Pfizer Inc (NYSE:PFE) is trading down 0.10% at 49.60 Pfizer Inc (NYSE:PFE)said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial. Pfizer said it...
Johnson & Johnson (NYSE: JNJ) Inc is trading up 0.96% at 159.20 People who got Johnson & Johnson (NYSE: JNJ) Inc’s COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer (NYSE: PFE) Inc/BioNTech SE or Moderna (NASDAQ: MRNA) Inc, a study...
Pfizer Inc is trading down 0.84% at 43.57 Pfizer Inc and BioNTech SE (NASDAQ:BNTX) on Tuesday submitted initial trial data for their COVID-19 vaccine in children aged 5 to 11 and said they would make a formal request with U.S. regulators for emergency use in the coming weeks. Coronavirus...
1.VOLKSWAGEN: Software Volkswagen AG used to alter pollutant emissions based on the outside temperature and altitude is illegal and cannot be justified by its role in protecting the engine, an adviser to the EU’s top court said on Thursday. The finding, if confirmed by the Court of Justice of...
Pfizer Inc (NYSE:PFE) is trading down 1.30% at 43.89 Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for authorization to use the vaccine in children in that age...
Pfizer (NYSE:PFE) is trading flat at 46.84 Top U.S. infectious disease expert Rd. Anthony Fauci said on Sunday that officials were likely to soon get the regulatory go-ahead to administer COVID-19 vaccine booster shots made byPfizer(NYSE:PFE), althoughModerna(NASDAQ:MRNA) booster could take a little longer. Asked on CBS’ “Face the Nation,”...
Pfizer (NYSE:PFE)is trading up 0.24% at 47.50 Pfizer Inc on Wednesday said a booster dose of its two-shot COVID-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the company seeks U.S. regulatory approval for a third injection. The drugmaker and its German partner BioNTech...
1. PFIZER:Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmaker’s top scientist said on Thursday, based on evidence of greater risk of reinfection six months after inoculation and the spread of the highly contagious Delta variant....